The largest database of trusted experimental protocols

Stereotaxic injector

Manufactured by Stoelting
Sourced in United States

The Stereotaxic Injector is a precision instrument designed for accurate and controlled delivery of micro-volumes of liquids or solutions into targeted regions of the brain or other tissues. It provides reliable and consistent injection parameters to support various research and experimental applications.

Automatically generated - may contain errors

7 protocols using stereotaxic injector

1

Inhibitory DREADD Manipulation of NAc-VP Circuitry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surgery was performed under aseptic conditions with isoflurane anesthesia. Infusions were made using a 33-gauge beveled needle (World Precision Instruments) and stereotaxic injector (Stoelting). For rats in the NAc shell-VP disconnection experiments, rats received unilateral infusions of an inhibitory DREADD (AAV8-hSyn-Gi-hM4Di-mCitrine; UNC vector core) into the NAc shell (1.0 μl) and VP (0.8 μl) in either opposite hemispheres (Group Contra; n = 14) or the same hemisphere (Group Ipsi; n =12). Coordinates for NAc shell infusions were 1.4 mm anterior of bregma, 0.8 mm from the midline, and 7.2 mm ventral from the skull surface. Coordinates for VP infusions were 0.12 mm anterior of bregma, 2.4 mm from the midline, and 8.2 mm ventral from the skull surface. The location of infusions (i.e., left or right hemisphere) was counterbalanced for each group. For the NAc shell experiment, rats received bilateral infusions (1.0 μl) of either an inhibitory DREADD (same as above; Group Gi; n = 7) or a green fluorescent protein (AAV8-hSyn-GFP; UNC vector core). The coordinates for NAc shell infusions were the same as above. All infusions were made at a rate of 0.15 μl/min. Transgene expression was allowed to take place for 3 weeks before the start of behavioral training.
+ Open protocol
+ Expand
2

Intracranial Glioma Models and Immunotherapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6 mice were intracranially inoculated with Quad-GL261 (1 x 105) or SB28 (5 x 104) cells in 2 μl of PBS at the bregma 3 mm to the right side of sagittal suture and 3.5 mm below the surface of skull using stereotactic frame (David Kopf Instruments, Tujunga, CA), stereotaxic injector (Stoelting Co., Wood Dale, IL) and 10 μl Hamilton syringe (Hamilton, Nero, NV) under anesthesia on day 0. The therapy started on day 13: anti-CD40 mAb (100 μg in 100 μl of PBS/mouse) on day 13 or days 13 and 23 intraperitoneally (i.p.), and/or celecoxib (Celebrex, Pfizer, 150 ppm in powdered diet) through days 13 to 33 via diet. In de novo glioma model, after establishment of gliomas was confirmed using BLI between days 30–40 following the glioma-induction, mice received: anti-CD40 mAb (100 μg in 100 μl of PBS/mouse) on days T0 and T10 i.p. and celecoxib (150 ppm in powdered diet) through days T0 to T15 via diet (Day T0 was defined as the first day of therapy following the confirmation of glioma establishment). Rat IgG2a isotype control and powdered diet without celecoxib were used for mock treatment. Mice were sacrificed when they showed any of following signs: hunchback, seizures, hemiparesis or weight loss of greater than 20%.
+ Open protocol
+ Expand
3

Orthotopic Brain Tumor Xenograft Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal procedures were approved by the Johns Hopkins University Animal Care and Use Committee. Prior to transplantation, GBM1, GBM551, and DIPG neurospheres were harvested, dissociated into single cells, and suspended in phosphate buffered saline (PBS) at a final concentration of 1 × 105/μL. The total 2 × 105 cells were loaded into a 10-μL Hamilton syringe with an attached 31-gauge needle and injected at a rate of 1 μL/min into the right striatum (anteroposterior = 1.0 mm; mediolateral = 2.0 mm; dorsoventral = 2.5 mm) of C57BL/6 J mice (8–10 weeks, n = 5 for each cell line) and SCID mice (8–10 weeks, n = 5 for each cell line, The Jackson Laboratory) through a stereotaxic injector (Stoelting). After the injection was complete, the needle was kept in place for 2 minutes and then withdrawn to avoid backflow of the injected cells through the needle tract.
For T-cell costimulatory blockade experiments, hamster anti-mouse CD154mAb (MR1, BioXcell) and CTLA-4-Ig (Abatacept, Bristol-Myers Squibb) were administered to C57BL/6 J mice (500 μg each) intraperitoneally (i.p.) on d 0, 2, 4, and 6 after tumor inoculation. Mice were monitored twice a week for weight changes and neurological symptoms.
+ Open protocol
+ Expand
4

Retrograde Labeling of Cochlear Root Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
To label CRNs and the cochlear nerve, we used identical procedures to those used in our previous studies (Gómez-Nieto et al., 2008b (link); Gómez-Nieto and Rubio, 2009 (link)). Three animals received a unilateral injection of the fluorescent tracer, dextran fluorescein isothiocyanate (D-FITC; #D-1820; Molecular Probes, Eugene, OR), into the left TB to label CRNs retrogradely. The stereotaxic coordinates targeted the course of CRN axons which project to PnC neurons via the TB (López et al., 1999 (link)). A volume of 0.15–0.2μl of D-FITC (10% in distilled water) were pressure-delivered with a Hamilton syringe (#710; Hamilton Co., Reno, NV) attached to a Stereotaxic Injector (Stoelting Co., Wood Dale, IL). After the scalp was sutured, the animals were allowed to recover for 4–7 days. Then, the animals were deeply anesthetized and perfused through the heart with 0.5% paraformaldehyde (PFA) in 0.1 M phosphate buffer, pH 7.4. The cochlea was removed, and crystals of the lipophylic dye DiI (#D-3911; 1.1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate; Molecular Probes) were placed on the exposed auditory nerve. The brains were stored in 4% PFA for approximately 30 days at room temperature protected from light and were processed for confocal microscopy as described by Gómez-Nieto and Rubio (2009 (link)).
+ Open protocol
+ Expand
5

Targeted Gene Silencing in Rat Dentate Gyrus

Check if the same lab product or an alternative is used in the 5 most similar protocols
On PND 44–45, rats received bilateral microinjections of either AAV-control or AAV-αCAMKII-kd virus vector in the dDG. 1 μl of viral vector suspension was injected in each hemisphere (0.15 μl/min) through a 10 μl Hamilton syringe (30G) connected to a motorized nanoinjector (Stereotaxic Injector, Stoelting, Wood Dale, USA) (Saha et al., 2018 (link); Tripathi et al., 2021 (link)).
+ Open protocol
+ Expand
6

S100B Striatal Injection in Rodents

Check if the same lab product or an alternative is used in the 5 most similar protocols
S100B was prepared in saline vehicle and injected into the striatum using a stereotaxic injector (Stoelting, Wood Dale, IL) with the animals under isoflurane / nitrous oxide anesthesia. Injection coordinates (relative to the bregma) were 1.0 mm anterior, 1.9 mm lateral and 3.5 mm deep. Needle track injuries were induced with vehicle injections alone.
+ Open protocol
+ Expand
7

Stereotactic Injection of Cells in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal experiments were conducted according to the European Union Community Council guidelines and were approved by the Animal Ethics Committee of the KU Leuven. Before surgery, animals were anaesthetized by an intraperitoneal injection with a mixture of ketamine (Ketamine1000, 4.5 mg/kg; Ceva, Pompidou, France)/medetomidin (Domitor®, 0.6 mg/kg; Pfizer, New York, USA). Local analgesia (2 % xylocain; AstraZeneca, London, UK) and antibiotics (6 mg/mouse, Ampiveto-20, 200 mg/ml; VMD, New Haw, Surrey, UK) were administered prior to surgery. After fixation of the animals in a stereotactic frame adapted with a stereotaxic injector (both from Stoelting, Wood Dale, USA), cells were suspended in 5 μl phosphate-buffered saline (PBS) and injected (0.5 μl/min) with a 10 μl Hamilton syringe, equipped with a 22 G needle, into the right striatum of C57Bl6/j mice at the following coordinates: 0.5 mm anterior and 2.0 mm lateral to bregma at 3.0 mm from the dura.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!